辉瑞(PFE)宣布成功完成对生物制药公司Metsera的收购

金吾财讯
Nov 14

金吾财讯 | 辉瑞(PFE)宣布成功完成对Metsera公司的收购。Metsera是一家临床阶段的生物制药公司,致力于开发针对肥胖症及心血管代谢疾病的新一代药物。7日,辉瑞同意以100亿美元收购Metsera,此前该公司与诺和诺德就后者展开激烈竞购。Metsera宣布,已与辉瑞达成修订版合并协议。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10